Tafenoquine versus Primaquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria

Alejandro Llanos‐Cuentas, Marcus Lacerda, Tran Tinh Hien, +28

New England Journal of Medicine

A Randomized Trial of Prolonged Co-trimoxazole in HIV-Infected Children in Africa

Mutsa Bwakura‐Dangarembizi, Lindsay Kendall, Sabrina Bakeera–Kitaka, +13

New England Journal of Medicine

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Nicholas I. Paton, Cissy Kityo, Immaculate Nankya, +286

The Lancet HIV

The Pharmacokinetics and Acceptability of Lopinavir/Ritonavir Minitab Sprinkles, Tablets, and Syrups in African HIV-Infected Children

Victor Musiime, Quirine Fillekes, Adeodata Kekitiinwa, +9

JAIDS Journal of Acquired Immune Deficiency Syndromes

Knowledge, attitude and practice towards tuberculosis in Gambia: a nation-wide cross-sectional survey

Adedapo Olufemi Bashorun, Christopher Linda, Semeeh Akinwale Omoleke, +8

BMC Public Health

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance

Florian Gehre, Jacob Otu, Lindsay Kendall, +41

BMC Medicine

Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial

Susana Scott, Umberto D’Alessandro, Lindsay Kendall, +24

Clinical Infectious Diseases

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé, +263

The Lancet Infectious Diseases

Pediatric Underdosing of Efavirenz

Quirine Fillekes, Eva Natukunda, J Balungi, +8

JAIDS Journal of Acquired Immune Deficiency Syndromes

Pharmacokinetics of Antiretroviral Drug Varies With Formulation in the Target Population of Children With HIV-1

Phillip Kasirye, Lindsay Kendall, Kimberly K. Adkison, +9

Clinical Pharmacology & Therapeutics